2014-13411. Submission for OMB Review; 30-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCI)
-
Start Preamble
SUMMARY:
Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on March 18, 2014, Vol. #79, page 15133 and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974, Attention: NIH Desk Officer.Start Printed Page 32966
Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
To obtain a copy of the data collection plans and instruments or request more information on the proposed project contact: Vivian Horovitch-Kelley, Office of Management Policy and Compliance, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD 20892-9760 or call non-toll-free number 240-276-6850 or Email your request including your address to: horovitchkellv@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing.
Proposed Collection: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCI), 0925-0642, Expiration Date 9/31/2014, Extension, National Cancer Institute (NCI), National Institutes of Health (NIH).
Need and Use of Information Collection: There are no changes being requested for this submission. The information collection activity will garner qualitative customer and stakeholder feedback in an efficient, timely manner, in accordance with the Administration's commitment to improving service delivery. This generic will provide information about the National Cancer Institute's customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. It will also allow feedback to contribute directly to the improvement of program management. Feedback collected under this generic clearance will provide useful information but it will not yield data that can be generalized to the overall population.
OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated burden hours are 8,750.
Start SignatureEstimated Annualized Burden Hours
Type of collection Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden hours Surveys 1000 1 30/60 500 In-Depth Interviews (IDIs) or Small Discussion Groups 500 1 90/60 750 Focus Groups 2000 1 90/60 3,000 Website or Software Usability Tests 3000 1 90/60 4,500 Dated: May 27, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2014-13411 Filed 6-6-14; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Published:
- 06/09/2014
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2014-13411
- Dates:
- Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.
- Pages:
- 32965-32966 (2 pages)
- PDF File:
- 2014-13411.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute